Search - tctmd.com

Displaying 21 - 40 of 106

Sort: Relevancy | Date

SUMMIT: Tirzepatide ‘Huge Win’ for HFpEF Patients With Obesity

News Conference News AHA 2024

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

Michael O'Riordan

November 16, 2024

News Conference News EACTS 2024

Will Semaglutide Change Cardiac Surgery? It Already Has

Yael L. Maxwell

October 10, 2024

News Daily News

Liraglutide Helps Shed Weight in Young Children With Obesity

Todd Neale

September 13, 2024

News Daily News

Schoolwide Intervention May Improve Obesity Outcomes Over Time

Yael L. Maxwell

July 29, 2024

News Daily News

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

Yael L. Maxwell

June 26, 2024

News Daily News

As Trends Reverse in CVD, AHA Warns of Soaring Costs and Illness

L.A. McKeown

June 05, 2024

News Daily News

BP Reductions Last 5 Years After Bariatric Surgery: GATEWAY

Michael O'Riordan

February 07, 2024

News Opinion CV Team Dispatch

February 2024 Dispatch for the CV Team

L.A. McKeown

February 01, 2024

News Daily News

Top General Cardiology and CVD Prevention News of 2023

Yael L. Maxwell

January 03, 2024

News Opinion CV Team Dispatch

January 2024 Dispatch for the CV Team

L.A. McKeown

January 01, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2023

Caitlin E. Cox

December 28, 2023

News Daily News

‘Smoldering Epidemic’ of CVD Risk Factors in Middle-Aged Adults

Michael O'Riordan

November 21, 2023

News Daily News

Mortality Risk Varies Among Patients With Very High LDL Levels

Michael O'Riordan

November 17, 2023

News Conference News AHA 2023

Full SELECT Results Affirm CV Risk Reduction With Semaglutide in Nondiabetics

Todd Neale

November 11, 2023

News Daily News

PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY

Michael O'Riordan

September 29, 2023

News Daily News

Lorundrostat, an Aldosterone Synthase Inhibitor, Passes Phase II Hurdle

Todd Neale

September 12, 2023

News Conference News ESC 2023

STEP-HFpEF: Semaglutide Cuts Weight and Symptoms, Boosts Function

Shelley Wood

August 25, 2023

News Daily News

A Mix of Aerobic and Strength Exercise Is Best for Boosting Survival

Caitlin E. Cox

August 09, 2023

News Daily News

CVD Risk Reduction With Exercise Also Seen in ‘Weekend Warriors’

Michael O'Riordan

July 24, 2023

News Conference News ADA 2023

Oral, Daily Semaglutide Cuts Pounds in Nondiabetic Patients: OASIS 1

Shelley Wood

June 29, 2023

Advertisement

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

Will Semaglutide Change Cardiac Surgery? It Already Has

Liraglutide Helps Shed Weight in Young Children With Obesity

Schoolwide Intervention May Improve Obesity Outcomes Over Time

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

As Trends Reverse in CVD, AHA Warns of Soaring Costs and Illness

BP Reductions Last 5 Years After Bariatric Surgery: GATEWAY

February 2024 Dispatch for the CV Team

Top General Cardiology and CVD Prevention News of 2023

January 2024 Dispatch for the CV Team

TCTMD’s Top 10 Most Popular Stories for December 2023

‘Smoldering Epidemic’ of CVD Risk Factors in Middle-Aged Adults

Mortality Risk Varies Among Patients With Very High LDL Levels

Full SELECT Results Affirm CV Risk Reduction With Semaglutide in Nondiabetics

PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY

Lorundrostat, an Aldosterone Synthase Inhibitor, Passes Phase II Hurdle

STEP-HFpEF: Semaglutide Cuts Weight and Symptoms, Boosts Function

A Mix of Aerobic and Strength Exercise Is Best for Boosting Survival

CVD Risk Reduction With Exercise Also Seen in ‘Weekend Warriors’

Oral, Daily Semaglutide Cuts Pounds in Nondiabetic Patients: OASIS 1

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content